Claybrook Capital’s Dorman Products DORM Stock Holding History

Claybrook Capital’s Portfolio DORM Stock Details DORM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-248	Closed	-$22K	–	236
2018 Q4	$22K	Buy	+248	New	+$19.8K	0.01%	343

Other funds holding DORM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Claybrook Capital's DORM Position: Q1 2019 in Review

Claybrook Capital sold out of Dorman Products (DORM) in Q1 2019, closing a stake of 248 shares — an estimated $22K sold.

Claybrook Capital first reported a position in DORM in Q4 2018 and held it in 1 quarter. The position peaked at $22K in Q4 2018. 251 funds tracked by Wall St. Rank hold DORM as of Q1 2019.

Claybrook Capital reported no remaining Dorman Products position as of Q1 2019 after selling out during the quarter.
Claybrook Capital sold 248 Dorman Products shares in Q1 2019, an estimated $22K.
Claybrook Capital first reported a position in Dorman Products in Q4 2018 and held it in 1 quarter.
Claybrook Capital's Dorman Products position peaked at $22K in Q4 2018.
251 funds tracked by Wall St. Rank held Dorman Products as of Q1 2019.

Based on Claybrook Capital's 13F filing for Q1 2019, filed 15 May 2019.